Abstract
Transcatheter aortic valve replacement is an established therapy for high-risk patients with severe aortic stenosis. Mitral annular calcification and degenerative mitral stenosis are commonly seen in this patient population. Concomitant mitral stenosis may pose a challenge in both patient selection
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have